Söndag 27 September | 21:12:45 Europe / Stockholm
Est. tid*
2027-02-25 07:30 Kvartalsrapport 2027-Q3
2026-11-25 07:30 Kvartalsrapport 2027-Q2
2026-09-04 - X-dag halvårsutdelning EKTA B 1.2
2026-09-03 - Årsstämma
2026-08-27 - Kvartalsrapport 2027-Q1
2026-05-28 - Bokslutskommuniké 2026
2026-03-05 - X-dag halvårsutdelning EKTA B 1.2
2026-03-05 - Kvartalsrapport 2026-Q3
2025-11-26 - Kvartalsrapport 2026-Q2
2025-09-05 - X-dag halvårsutdelning EKTA B 1.2
2025-09-04 - Årsstämma
2025-08-28 - Kvartalsrapport 2026-Q1
2025-05-28 - Bokslutskommuniké 2025
2025-03-06 - X-dag halvårsutdelning EKTA B 1.2
2025-02-21 - Kvartalsrapport 2025-Q3
2024-11-27 - Kvartalsrapport 2025-Q2
2024-09-06 - X-dag halvårsutdelning EKTA B 1.2
2024-09-05 - Årsstämma
2024-08-28 - Kvartalsrapport 2025-Q1
2024-06-05 - Bokslutskommuniké 2024
2024-02-29 - Kvartalsrapport 2024-Q3
2024-02-26 - X-dag halvårsutdelning EKTA B 1.2
2023-11-30 - Kvartalsrapport 2024-Q2
2023-08-25 - X-dag halvårsutdelning EKTA B 1.2
2023-08-24 - Årsstämma
2023-08-24 - Kvartalsrapport 2024-Q1
2023-05-25 - Bokslutskommuniké 2023
2023-02-24 - X-dag halvårsutdelning EKTA B 1.2
2023-02-24 - Kvartalsrapport 2023-Q3
2022-11-24 - Kvartalsrapport 2023-Q2
2022-08-26 - X-dag halvårsutdelning EKTA B 1.2
2022-08-25 - Årsstämma
2022-08-25 - Kvartalsrapport 2023-Q1
2022-05-25 - Bokslutskommuniké 2022
2022-02-24 - X-dag halvårsutdelning EKTA B 1.1
2022-02-24 - Kvartalsrapport 2022-Q3
2021-11-25 - Kvartalsrapport 2022-Q2
2021-08-26 - X-dag halvårsutdelning EKTA B 1.1
2021-08-25 - Årsstämma
2021-08-25 - Kvartalsrapport 2022-Q1
2021-05-28 - Bokslutskommuniké 2021
2021-04-19 - X-dag bonusutdelning EKTA B 0.9
2021-04-16 - Extra Bolagsstämma 2021
2021-02-25 - Kvartalsrapport 2021-Q3
2020-11-26 - Kvartalsrapport 2021-Q2
2020-08-27 - X-dag halvårsutdelning EKTA B 0.9
2020-08-26 - Årsstämma
2020-08-26 - Kvartalsrapport 2021-Q1
2020-05-29 - Bokslutskommuniké 2020
2020-02-21 - X-dag halvårsutdelning EKTA B 0.9
2020-02-20 - Kvartalsrapport 2020-Q3
2019-11-28 - Kvartalsrapport 2020-Q2
2019-08-23 - X-dag halvårsutdelning EKTA B 0.9
2019-08-22 - Årsstämma
2019-08-22 - Kvartalsrapport 2020-Q1
2019-05-29 - Bokslutskommuniké 2019
2019-03-01 - X-dag halvårsutdelning EKTA B 0.7
2019-02-22 - Kvartalsrapport 2019-Q3
2018-11-29 - Kvartalsrapport 2019-Q2
2018-08-31 - X-dag halvårsutdelning EKTA B 0.7
2018-08-30 - Årsstämma
2018-08-30 - Kvartalsrapport 2019-Q1
2018-06-01 - Bokslutskommuniké 2018
2018-03-02 - Kvartalsrapport 2018-Q3
2018-02-22 - X-dag halvårsutdelning EKTA B 0.5
2017-11-30 - Kvartalsrapport 2018-Q2
2017-08-24 - X-dag halvårsutdelning EKTA B 0.5
2017-08-23 - Årsstämma
2017-08-23 - Kvartalsrapport 2018-Q1
2017-06-01 - Bokslutskommuniké 2017
2017-03-03 - X-dag halvårsutdelning EKTA B 0.25
2017-03-01 - Kvartalsrapport 2017-Q3
2016-12-01 - Kvartalsrapport 2017-Q2
2016-09-26 - Kapitalmarknadsdag 2016
2016-09-02 - X-dag halvårsutdelning EKTA B 0.25
2016-09-01 - Årsstämma
2016-09-01 - Kvartalsrapport 2017-Q1
2016-06-01 - Bokslutskommuniké 2016
2016-03-02 - Kvartalsrapport 2016-Q3
2015-12-03 - Kvartalsrapport 2016-Q2
2015-09-02 - X-dag ordinarie utdelning EKTA B 0.50 SEK
2015-09-01 - Årsstämma
2015-09-01 - Kvartalsrapport 2016-Q1
2015-06-02 - Bokslutskommuniké 2015
2015-03-04 - Kvartalsrapport 2015-Q3
2014-11-27 - Analytiker möte 2014
2014-11-27 - Kvartalsrapport 2015-Q2
2014-09-15 - Kapitalmarknadsdag 2014
2014-08-29 - X-dag bonusutdelning EKTA B 0.5
2014-08-29 - X-dag ordinarie utdelning EKTA B 1.50 SEK
2014-08-28 - Analytiker möte 2015
2014-08-28 - Årsstämma
2014-08-28 - Kvartalsrapport 2015-Q1
2014-05-28 - Analytiker möte 2014
2014-05-28 - Bokslutskommuniké 2014
2014-02-27 - Kvartalsrapport 2014-Q3
2013-12-04 - Kvartalsrapport 2014-Q2
2013-09-23 - Kapitalmarknadsdag 2013
2013-09-04 - X-dag bonusutdelning EKTA B 0.5
2013-09-04 - X-dag ordinarie utdelning EKTA B 1.50 SEK
2013-09-03 - Årsstämma
2013-09-03 - Kvartalsrapport 2014-Q1
2013-06-05 - Analytiker möte 2013
2013-06-05 - Bokslutskommuniké 2013
2013-03-05 - Extra Bolagsstämma 2013
2013-03-05 - Kvartalsrapport 2013-Q3
2012-12-04 - Kvartalsrapport 2013-Q2
2012-10-29 - Kapitalmarknadsdag 2012
2012-09-12 - Split EKTA B 1:4
2012-09-05 - X-dag ordinarie utdelning EKTA B 5.00 SEK
2012-09-03 - Årsstämma
2012-09-03 - Kvartalsrapport 2013-Q1
2012-06-05 - Analytiker möte 2012
2012-06-05 - Bokslutskommuniké 2012
2012-04-02 - Extra Bolagsstämma 2012
2012-03-05 - Kvartalsrapport 2012-Q3
2011-12-02 - Kvartalsrapport 2012-Q2
2011-09-14 - X-dag ordinarie utdelning EKTA B 4.00 SEK
2011-09-13 - Årsstämma
2011-09-13 - Kvartalsrapport 2012-Q1
2011-06-09 - Bokslutskommuniké 2011
2011-03-08 - Kvartalsrapport 2011-Q3
2010-12-07 - Kvartalsrapport 2011-Q2
2010-09-22 - X-dag ordinarie utdelning EKTA B 3.00 SEK
2010-09-21 - Kvartalsrapport 2011-Q1
2010-06-09 - Bokslutskommuniké 2010
2010-03-10 - Kvartalsrapport 2009-Q3
2009-12-10 - Kvartalsrapport 2009-Q2
2009-09-16 - X-dag ordinarie utdelning EKTA B 2.00 SEK
2009-09-15 - Årsstämma
2009-09-15 - Kvartalsrapport 2009-Q1
2008-09-19 - X-dag ordinarie utdelning EKTA B 1.75 SEK
2007-09-26 - X-dag ordinarie utdelning EKTA B 1.00 SEK
2006-09-21 - X-dag ordinarie utdelning EKTA B 1.00 SEK
2005-10-17 - Split EKTA B 1:3
2005-09-22 - X-dag ordinarie utdelning EKTA B 6.60 SEK
2004-09-22 - X-dag ordinarie utdelning EKTA B 0.00 SEK
2003-09-23 - X-dag ordinarie utdelning EKTA B 0.00 SEK
2002-10-01 - X-dag ordinarie utdelning EKTA B 0.00 SEK
2001-09-28 - X-dag ordinarie utdelning EKTA B 0.00 SEK
2000-10-02 - X-dag ordinarie utdelning EKTA B 0.00 SEK
1999-09-23 - X-dag ordinarie utdelning EKTA B 0.00 SEK
LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Elekta är verksamt inom medicinteknikbranschen och fokuserar på utveckling, tillverkning och distribution av medicinsk utrustning för cancerbehandling och neurokirurgi. Bolagets produkter inkluderar strålterapimaskiner och bilddiagnostiksystem. Bolaget har en global marknadsposition. Elekta grundades år 1972 och har sitt huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Elekta expands adaptive workflows across its radiotherapy portfolio

2026-09-27 17:40:00

New capabilities across CT, MR, radiosurgery and brachytherapy give centers more ways to bring adaptive treatment into everyday clinical practice.

BOSTON – Elekta (EKTA-B.ST) today announced the expansion of its adaptive radiotherapy portfolio at ASTRO. With capabilities spanning CT- and MR-guided radiotherapy, radiosurgery and brachytherapy, Elekta is giving clinicians more ways to personalize treatment while addressing the clinical, operational and resource demands that can limit broader adoption of adaptive radiotherapy. The portfolio is enabled by Elekta ONE software.

Elekta’s adaptive portfolio spans MR-guided radiotherapy with Elekta Unity, CT-guided online adaptive radiotherapy with Elekta Evo, and online adaptive radiosurgery with Leksell Gamma Knife Esprit. The portfolio is now expanding with online adaptive capability for Elekta Harmony and real-time adaptive planning in prostate brachytherapy with Elekta Prostate Guideway.

Elekta Harmony, one of Elekta’s CT-Linac platforms, now supports online adaptive workflows enabled by Elekta ONE Online. The new capability allows clinicians to assess the patient’s anatomy at the time of treatment and adapt the treatment plan only when needed.

Elekta Harmony is designed for everyday throughput, with guided workflows and automation that support efficient treatment delivery. Adding online adaptive capability gives cancer centers a practical way to introduce adaptive radiotherapy while continuing to manage patient volumes and clinical resources.

“For adaptive radiotherapy to reach more patients, it has to fit into daily clinical practice,” said Chirag Shah, MD, Chair, Department of Radiation Oncology, Allegheny Health Network. “Different patients and disease sites need different approaches, and the workflows have to be practical and efficient for our team and clinically appropriate for the patient. Having adaptive options across Elekta’s portfolio helps us deliver the same high-quality care across our network.”

The portfolio launch also includes Elekta Prostate Guideway, which brings adaptive workflows into HDR prostate brachytherapy. The solution integrates imaging, planning and treatment adaptation together in a connected, single-room workflow. Continuous dose recalculation and efficient plan updates allow clinicians to respond to anatomical changes and needle shifts as they occur.

Diagnostic MRI and biopsy information can be incorporated into the live treatment workflow, while immediate visual feedback shows how the evolving plan compares with clinical objectives. This supports informed targeting and treatment-planning decisions throughout the procedure.

“In a dynamic interventional procedure like prostate brachytherapy, having the right information at the right time can make a meaningful difference,” said John Lapré, Chief Business Line Officer – Brachytherapy Solutions at Elekta. “When clinicians can continuously see the impact of changes and receive clear guidance, they can adapt treatment with greater confidence.” 

Together, these developments extend Elekta’s adaptive offering across MR-guided and CT-guided radiotherapy, Gamma Knife radiosurgery and image-guided brachytherapy, giving clinicians greater flexibility to select the imaging and workflow best suited to the patient, indication and clinical need.

Product availability and regulatory status vary by market. Prostate Guideway is pre-commercial and pending U.S. FDA 510(k) clearance and EU CE marking.

# # #

For further information, please contact:
Kathy Pajari, Head of Corporate Communications
Tel: +46 76 255 6056, e-mail: Kathy.Pajari@elekta.com
Time zone: CEST (Central European Summertime)

About Elekta
Elekta is shaping the standard of care, together with healthcare providers, by developing precision radiation medicine that brings advanced radiotherapy into routine clinical practice. Our solutions support consistent, efficient and personalized care, addressing evolving patient needs. Through adaptive radiotherapy, precision treatment delivery and integrated workflows, Elekta supports care teams across a range of clinical settings. Each year more than 2 million patients are treated using Elekta solutions across 130 countries. Elekta is headquartered in Stockholm, Sweden, with over 4,000 employees and offices in more than 40 countries. The company is listed on Nasdaq Stockholm. For more information, visit elekta.com